Perioperative Ivonescimab Plus S-1 and Oxaliplatin (SOX) for Locally Advanced Gastric or GEJ Adenocarcinoma

NCT07374250 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

154

Enrollment

OTHER

Sponsor class

Conditions

Gastric Cancer
RCT

Interventions

DRUG: Ivonescimab (20mg/kg Q3W)
DRUG: Oxaliplatin
DRUG: S-1

Sponsor

Sichuan University